ALKS Buy Disclosure
Hon. Gilbert Cisneros · U.S. House PTR · Filed Oct 12, 2026
Buy
Reported value range
$1K - $15K
Hon. Gilbert Cisneros
U.S. House member
ALKS
Alkermes Inc
ALKS
Transaction date
Sep 29, 2026
Public filing date
Oct 12, 2026
Filing lag
Filed 13 days later
ALKS daily price context
Close on/before transaction
$40.8
Sep 29, 2026
First close after public filing
$39.73
Oct 13, 2026
Return after filing · so far
+13.82%
Through Nov 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- ST
- Security
- Alkermes plc - Ordinary Shares (ALKS) [ST]
- Quantity / price
- Not reported
- Transaction code
- P
- Form
- P
- Filing identifier
- house_ptr:2026:20035622:3
Filing cohort
Transactions in this filing
Showing 15 of 57
Trades
57
Issuers
51
Estimated value
$2.11M
Buys / sales
29 / 27
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Benchmark Electronics, Inc. Common Stock BHE | Buy | Oct 1, 2026 | $15K - $50K |
| Thermon Group Holdings, Inc. Common Stock THR | Exchange | Oct 1, 2026 | $15K - $50K |
| Advanced Energy Industries, Inc. - Common Stock AEIS | Buy | Sep 29, 2026 | $1K - $15K |
| Allegro MicroSystems, Inc. - Common Stock ALGM | Buy | Sep 29, 2026 | $1K - $15K |
| Alkermes plc - Ordinary Shares ALKS Current | Buy | Sep 29, 2026 | $1K - $15K |
| AtriCure, Inc. - Common Stock ATRC | Sale | Sep 29, 2026 | $1K - $15K |
| BridgeBio Pharma, Inc. - Common Stock BBIO | Sale | Sep 29, 2026 | $1K - $15K |
| Cytokinetics, Incorporated - Common Stock CYTK | Buy | Sep 29, 2026 | $1K - $15K |
| Gates Industrial Corporation Ltd. Common Shares GTES | Buy | Sep 29, 2026 | $1K - $15K |
| Halozyme Therapeutics, Inc. - Common Stock HALO | Sale | Sep 29, 2026 | $1K - $15K |
| ITT Inc. Common Stock ITT | Sale | Sep 29, 2026 | $15K - $50K |
| MACOM Technology Solutions Holdings, Inc. - Common Stock MTSI | Sale | Sep 29, 2026 | $15K - $50K |
| Oxford Industries, Inc. Common Stock OXM | Sale | Sep 29, 2026 | $1K - $15K |
| Praxis Precision Medicines, Inc. - Common Stock PRAX | Buy | Sep 29, 2026 | $1K - $15K |
| Ultragenyx Pharmaceutical Inc. - Common Stock RARE | Buy | Sep 29, 2026 | $1K - $15K |